Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines.
about
Realistic expectations of prepulse inhibition in translational models for schizophrenia research.Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo [4,5-g]isoquinoline): discovery, pharmacological effects, and therapeutic potentialFunctional selectivity of central Gα-subunit proteins in mediating the cardiovascular and renal excretory responses evoked by central α(2) -adrenoceptor activation in vivoClonidine normalizes sensorimotor gating deficits in patients with schizophrenia on stable medication.Corticotropin-releasing factor and noradrenergic signalling exert reciprocal control over startle reactivityPharmacological stimulation of locus coeruleus reveals a new antipsychotic-responsive pathway for deficient sensorimotor gating.Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating.Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine.Behavioral genetic contributions to the study of addiction-related amphetamine effects.Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depressionPharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis.α2-Adrenoceptors are targets for antipsychotic drugs.Alpha 2-adrenergic receptors decrease DNA replication and cell proliferation and induce neurite outgrowth in transfected rat pheochromocytoma cells.Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective.Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice.Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.
P2860
Q24645703-96A933A9-4553-4435-8912-BDB8EA9922A6Q24681582-3612A53E-F1AC-4E8D-BFAC-0BE4B3418DE8Q28260961-5C87B64A-44BB-45B6-B9EF-6522407E602CQ28575961-DDA7D14D-56FF-4593-BBA9-9E5B1F423541Q30439307-0ED5D1EB-20E4-473A-9E78-DF723B6177D6Q30456196-40172BB5-C591-44FA-88C8-D6648698B5EAQ30466233-27309FC7-263D-47D7-A5E9-7062D3BB90FEQ30469126-24BF0C0C-E6C1-4D3A-8916-85A8C63DF33CQ30475702-CC40ADA2-948B-446B-9C47-20D806C5EE43Q30494693-880CB7D3-6C68-4A1B-B101-1D942F1862C1Q33925526-1F9F7A86-7B32-47A9-B4DA-1C0A2AC81CD2Q37299577-552744DE-0206-4BCA-8C03-7D2209822C89Q38184439-44E63DA5-0C4D-458F-8D09-E0A2EF9F048FQ38306203-AC3195C6-19E3-40BC-A793-6BFF814610E4Q38635337-961AD1B9-32D0-42BF-8798-B9122483E9C0Q45981643-C971E273-F559-4931-BFB5-43D4D146D1EFQ50952384-5E73ECD3-B731-46E8-8013-4EBB3D016CB7
P2860
Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Alpha2A-adrenoceptors are impo ...... activity and brain monoamines.
@en
Alpha2A-adrenoceptors are impo ...... activity and brain monoamines.
@nl
type
label
Alpha2A-adrenoceptors are impo ...... activity and brain monoamines.
@en
Alpha2A-adrenoceptors are impo ...... activity and brain monoamines.
@nl
prefLabel
Alpha2A-adrenoceptors are impo ...... activity and brain monoamines.
@en
Alpha2A-adrenoceptors are impo ...... activity and brain monoamines.
@nl
P2093
P2860
P356
P1476
Alpha2A-adrenoceptors are impo ...... activity and brain monoamines.
@en
P2093
Ewen MacDonald
Janne Lähdesmäki
Jukka Sallinen
Mika Scheinin
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300428
P407
P577
2004-07-01T00:00:00Z
P6179
1051691229